Pharmaceuticals

Painkillers Increase Risk of Irregular Heartbeat

Painkillers Increase Risk of Irregular Heartbeat

Painkillers have been associated with higher risk of irregular heartbeat in older adults. Atrial fibrillation increases the risk of stroke and heart failure. The extensive study carried out by Dutch scientists has found some non-steroidal anti-inflammatory drugs (NSAIDs) causing irregular heartbeat.

Laboratories: 
Location: 

Effectiveness of Stockpiled Tamiflu and Relenza Questioned by UK based Research Organization

Effectiveness of Stockpiled Tamiflu and Relenza Questioned

The anti-flu drugs stockpiled by governments across the world including tamiful and relenza, might do more harm than offering benefit to individuals. As per the study conducted by UK based nonprofit research organization Cochrane Collaboration, the drugs tamiflu and relenza, stockpiled by governments to fight influenza outbreaks might cause harm after their team reviewed 170,000 pages of clinical trial records. Cochrane Collaboration has urged health department to carry out a detailed review about the role of flu drugs in controlling the spread of influenza.

Location: 
Laboratories: 

Pfizer Experimental Drug Shows Promising Results in Phase II Study

Pfizer Experimental Drug Shows Promising Results in Phase II Study

Pharmaceutical major Pfizer has reported encouraging results in an early clinical trial for experimental advanced breast cancer drug. The Phase II study of drug palbociclib carried out on 165 patients in combination with other therapies has shown positive outcomes.

Dr. Dennis Slamon, a physician at UCLA said that the results are impressive and the success of current study would help Pfizer get approval from U.S. FDA. Dr Slamon has worked with Pfizer on the research and development project for palbociclib.

Location: 
Laboratories: 
Company: 

FDA Approves Evzio for Naloxone treatment in Emergency cases opioid overdose

FDA Approves Evzio for Naloxone treatment in Emergency cases opioid overdose

The U.S. FDA has approved hand-held auto-injector Evzio, which can be used in emergency situations to counter the overdose of opioid painkillers. Opioid overdose is a major health issue in the United States, with more than 16,000 deaths reported each year due to overdose. FDA Commissioner Margaret A. Hamburg has issued an official statement urging health care professionals and other agencies to help FDA in controlling the abuse of opioid painkillers.

Laboratories: 
Location: 

Adempas, Bayer’s Lung Drug Wins Approval to Treat Pulmonary Hypertension

Adempas, Bayer’s Lung Drug Wins Approval to Treat Pulmonary Hypertension

The European Commission has given green signal to Bayer's Adempas to treat two types of pulmonary hypertensions in EU. The Adempas, also known as riociguat, has been approved for treating chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). The drug showed positive results in two randomized, double-blind, placebo-controlled trials. These tests include global Phase III studies CHEST-1 and PATENT-1 as well as long-term data from CHEST-2 and PATENT-2.

Location: 
Company: 

FDA Approves Biogen’s Hemophilia B Drug, Alprolix

FDA Approves Biogen’s Hemophilia B Drug, Alprolix

U.S. Food and Drug Administration (FDA) has given green signal to long-lasting hemophilia B drug to treat multiple sclerosis by Biogen Idec Inc. The company said that the drug has Factor IX molecule which makes the product last longer in circulation.

The drug, Alprolix, developed by collaboration of Biogen and Swedish Orphan Biovitrum AB (SOBI) has been approved to treat the blood disorder. Tony Kingsley, executive vice president of Biogen’s global commercial operations, said the current treatment performs several infusions a week, but the new drug reduces the need for infusions.

Laboratories: 
Company: 

FDA Rejects Approval of Novartis drug Serelaxin for Heart Failure

FDA Rejects Approval of Novartis drug Serelaxin for Heart Failure

The U. S. Food and Drug Administration (FDA) panel have voted against the Novartis AG experimental heart failure drug, Serelaxin. The agency said that the company has given insufficient evidence in support of the proposed indication and moreover reviewers have also not released safety concerns about the drug.

Location: 
Laboratories: 
Company: 

OTEZLA, Celgene’s Drug Gets Green Signal to Treat Psoriatic Arthritis

OTEZLA, Celgene’s Drug Gets Green Signal to Treat Psoriatic Arthritis

The U.S. Food and Drug Administration (FDA) review team has given approval to the Celgene Corp. drug, OTEZLA, to treat adult patients with active psoriatic arthritis. At the moment, OTEZLA is the only FDA-approved oral treatment for psoriatic arthritis.

Location: 
Laboratories: 
Company: 

Secukinumab, Novartis Psoriasis Drug Effective in Phase III Trial

Secukinumab, Novartis Psoriasis Drug Effective in Phase III Trial

Secukinumab, the experimental drug by the Novartis has proved successful in its two late-stage clinical trials to treat patients with moderate-to-severe plaque psoriasis. The findings of the Phase III studies were presented at the American Academy of Dermatology in Denver. The results revealed how the drug proved effective in clearing patients' skin when administered with a pre-filled syringe or autoinjector pen.

Location: 
Person: 
Company: 

Endocyte’s Vynfinit Drug Successful in Treating Ovarian and Lung Cancer

Endocyte’s Vynfinit Drug Successful in Treating Ovarian and Lung Cancer

The Endocyte Inc. ovarian cancer drug, Vynfinit, has gained green signal from European Union panel to treat patients with ovarian cancer. The drug has also proved successful in slowing down the progression of lung cancer, doubling the value of the biotechnology company as the stock gained after the approval was announced.

Location: 
Person: 
Company: 

Pages

Popular Stories

Harley-Davidson to turn 8 Dyna motorbikes into new Softail bikes

Betting big on cruisers, the luxury motorcycle... Read More

Uber’s net loss declines as ride bookings grow

Uber Technologies reported lower loss by nearly 9... Read More

Samsung Galaxy Note 8 facing challenges on multiple fronts

The Samsung Galaxy Note 8 is facing an increasingly... Read More

Leaked reports reveal more about new BMW M5

Luxury carmaker BMW’s next-generation M5 car will... Read More